Please assess the completion status of the following clinical trial:

Trial Title: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* active rheumatoid arthritis;~* receiving outpatient treatment;~* an inadequate response, or intolerance, to \>=1 anti-TNF agent.~Exclusion Criteria:~* other rheumatic autoimmune disease or inflammatory joint disease;~* concurrent treatment with any anti-TNF-alpha therapy;~* joint or osseous surgery during 8 weeks prior to recruitment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).